Format

Send to:

Choose Destination
See comment in PubMed Commons below
Arq Bras Endocrinol Metabol. 2011 Dec;55(9):686-91.

Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service.

Author information

  • 1Pharmaceutical Assistance and Clinical Pharmacy Research Center (CPAFF), Department of Pharmaceutical Sciences, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. paulanasa@yahoo.com.br

Abstract

OBJECTIVE:

To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service.

SUBJECTS AND METHODS:

A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist.

RESULTS:

The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits.

CONCLUSION:

The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.

PMID:
22231970
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Scientific Electronic Library Online
    Loading ...
    Write to the Help Desk